首页> 外文OA文献 >BCL-2, topoisomerase IIα, microvessel density and prognosis of early advanced breast cancer patients after adjuvant anthracycline-based chemotherapy

【2h】

BCL-2, topoisomerase IIα, microvessel density and prognosis of early advanced breast cancer patients after adjuvant anthracycline-based chemotherapy

机译：辅助蒽环类药物辅助化疗后早期晚期乳腺癌患者的BCL-2，拓扑异构酶IIα，微血管密度和预后

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Beata Biesaga; Joanna Niemiec; Marek Ziobro;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. BCL-2, topoisomerase IIα, microvessel density and prognosis of early advanced breast cancer patients after adjuvant anthracycline-based chemotherapy. [J] . Beata Biesaga, Joanna Niemiec, Marek Ziobro Journal of Cancer Research and Clinical Oncology . 2014,第12期

机译：辅助蒽环类药物辅助化疗后早期晚期乳腺癌患者的BCL-2，拓扑异构酶IIα，微血管密度和预后。
2. Topoisomerase IIalpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2eu-amplified breast cancer: Scandinavian Breast Group Trial 9401. [J] . Tanner M, Isola J, Wiklund T, Journal of Clinical Oncology . 2006,第16期

机译：拓扑异构酶IIalpha基因扩增可预测对HER-2 / neu扩增乳腺癌中基于量身定制和剂量递增的蒽环类辅助化疗的有利治疗反应：斯堪的纳维亚乳腺癌组试验9401。
3. Topoisomerase IIalpha expression rather than gene amplification predicts responsiveness of adjuvant anthracycline-based chemotherapy in women with primary breast cancer. [J] . Schindlbeck C, Mayr D, Olivier C, Journal of Cancer Research and Clinical Oncology . 2010,第7期

机译：拓扑异构酶IIalpha的表达而非基因扩增可预测原发性乳腺癌女性基于蒽环类辅助化疗的反应性。
4. Adjuvant Chemotherapy Should Not Routinely Be Recommended to Patients with Stage II Colon Cancers that Manifest Microsatellite Instability [C] . Sigurdis Haraldsdottir, Richard M. Goldberg Gastrointestinal Cancers Symposium . 2014

机译：不应常规向患有阶段结肠癌的患者常规的辅助化学疗法，表明微卫星不稳定性
5. The Effects of Adjuvant Chemotherapy on Brain Function in Breast Cancer Patients and a Cancer-Chemotherapy Rodent Model. [D] . Barr, Alicia Thomas. 2014

机译：辅助化疗对乳腺癌患者脑功能的影响和癌症化学疗法的啮齿动物模型。
6. BCL-2 topoisomerase IIα microvessel density and prognosis of early advanced breast cancer patients after adjuvant anthracycline-based chemotherapy [O] . Beata Biesaga, Joanna Niemiec, Marek Ziobro -1

机译：蒽环类辅助化疗后早期晚期乳腺癌患者BCL-2拓扑异构酶IIα微血管密度和预后
7. BRCAness as a Biomarker for Predicting Prognosis and Response to Anthracycline-Based Adjuvant Chemotherapy for Patients with Triple-Negative Breast Cancer. [O] . Hitomi Mori, Makoto Kubo, Reiki Nishimura, 2016

机译：BRCaness作为预测三阴性乳腺癌患者蒽环类辅助化疗预后和反应的生物标志物。

BCL-2, topoisomerase IIα, microvessel density and prognosis of early advanced breast cancer patients after adjuvant anthracycline-based chemotherapy

著录项

引文网络

相似文献

相关主题

期刊订阅